Facilitation of penicillin haptenation to serum proteins. by DiPiro, Joseph T. et al.
Virginia Commonwealth University
VCU Scholars Compass
Publications from the Office of the Dean Office of the Dean
1993
Facilitation of penicillin haptenation to serum
proteins.
Joseph T. DiPiro
Virginia Commonwealth University, University of Georgia, jtdipiro@vcu.edu
N. Franklin Adkinson Jr.
Johns Hopkins University
Robert G. Hamilton
Johns Hopkins University
Follow this and additional works at: http://scholarscompass.vcu.edu/pharmacy_dean_pubs
Part of the Pharmacy and Pharmaceutical Sciences Commons
© 1993, American Society for Microbiology
This Article is brought to you for free and open access by the Office of the Dean at VCU Scholars Compass. It has been accepted for inclusion in
Publications from the Office of the Dean by an authorized administrator of VCU Scholars Compass. For more information, please contact
libcompass@vcu.edu.
Downloaded from
http://scholarscompass.vcu.edu/pharmacy_dean_pubs/7
Vol. 37, No. 7ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 1993, P. 1463-1467
0066-4804/93/071463-05$02.00/0
Copyright © 1993, American Society for Microbiology
Facilitation of Penicillin Haptenation to Serum Proteins
JOSEPH T. DIPIRO,l* N. FRANKLIN ADKINSON, JR.,2 AND ROBERT G. HAMILTON2
University of Georgia College ofPharmacy and Medical College of Georgia, Augusta, Georgia 30912,1
and Asthma and Allergy Center, Johns Hopkins University School ofMedicine,
Baltimore, Maryland 212242
Received 2 October 1992/Accepted 9 May 1993
Traditionally, penicillin binding to serum proteins was believed to be a passive chemical process; however,
it appears to be facilitated by serum factors. The objectives of this in vitro investigation were to examine
facilitated penicillin haptenation, to study the kinetics of haptenation, and to determine the nature of
haptenation-facilitating factors. The model involved addition of [3HJbenzylpenicillin to serum or albumin
solutions (at pH 7.3 to 7.4) and incubation at 37°C for up to 72 h. The extent of penicillin binding to proteins
in serum was found to be four- to fivefold higher than with solutions having comparable concentrations of
purified albumin, total protein, or total immunoglobulin. Ultrafiltration of serum reduced penicillin binding to
serum proteins substantially. An ultrafiltrable haptenation-facilitating factor(s) was found to be less than 0.5
kDa but was not calcium or magnesium. Finally, the extent of penicillin binding was related to albumin purity,
as binding substantially increased with albumin purity. These findings suggest that there is a factor(s) in serum
that facilitates covalent binding of penicillin to serum proteins. The factor(s) can be removed and then restored
to increase penicillin binding to albumin. It appears that at least one component of the facilitation factor is less
than 0.5 kDa, which suggests that it is not a peptide and that it is some simple serum component other than
calcium or magnesium.
For 50 years, since its introduction, clinical use of peni-
cillin has been complicated by immediate hypersensitivity
reactions. Allergic reactions to penicillin have been reported
to occur in 0.7 to 8% of patients, depending on the study (3).
We have previously reported that penicilloyl-specific immu-
noglobulin G (IgG) and IgE were detected in 38 and 18% of
patients, respectively, who received >2 g of penicillin per
day for at least 10 days (1), suggesting that major determi-
nant-specific antibody responses are restricted to a minority
of the general population. We postulated that heterogeneity
of immune responsiveness to penicillin could be influenced
by individual differences in immunogen formation and clear-
ance, possibly involving differential rates of haptenation and
dehaptenation to carrier serum proteins.
Lee and Sullivan (2) have reported that penicillin hapte-
nation to serum proteins is facilitated and not passive.
Haptenation of penicillin to serum proteins was 4.0- to
5.3-fold greater than that to purified human serum albumin.
Sullivan (4) has also reported that penicillin may undergo
dehaptenation from albumin and that this process may
proceed at a lower rate in penicillin-allergic subjects.
A number of questions remain regarding the nature of
facilitated penicillin haptenation to serum proteins. Specifi-
cally, the kinetics of facilitated haptenation and the nature of
facilitating serum factors need to be addressed. The objec-
tives of this in vitro investigation were to extend the findings
of Lee and Sullivan regarding facilitated haptenation (2), to
study the kinetics of haptenation further, and to determine
the nature of facilitating factors.
MATERIALS AND METHODS
Materials. Serum was obtained from one healthy adult
male volunteer with no history of allergy. The total protein
and albumin in this serum were determined to be 7.2 and 4.6
* Corresponding author.
g/dl, respectively. Where noted, sera from additional non-
penicillin-allergic volunteers were tested. Three purity
grades of human serum albumin were used. These included
fraction V powder (A1653; Sigma Chemical Company, St.
Louis, Mo.), crystallized and lyophilized fraction V powder
(A9511; Sigma Chemical Company), and electrophoretically
prepared, 100% pure powder (18.501.904, lot 4965F; Behring
Diagnostics, Somerville, N.J.). Tritiated penicillin {phenyl-
4(n)-[3H]benzylpenicillin} was obtained as a 93.1 to 98.6%
pure solution with a specific activity of 10.5 to 25 Ci/mmol
(TRK 779; Amersham, Arlington Heights, Ill.). The activi-
ties of experimental samples were determined on a beta
counter (LS1701 Liquid Scintillation Counter; Beckman
Instruments, Columbia, Md.). Unlabeled benzylpenicillin
sodium was also obtained from Sigma Chemical Company.
Trichloroacetic acid was obtained as a 100% solution (490-
10; Sigma Chemical Company). Purified human IgG was
obtained commercially (Sandoglobulin; Sandoz Pharmaceu-
tical Corporation, East Hanover, N.J.). Phosphate-buffered
saline (PBS), pH 7.3 to 7.4, was prepared fresh for each
experiment. Ultrafiltrations were performed with an ultrafil-
tration cell (Amicon, Beverly, Mass.) with membranes hav-
ing nominal molecular mass cutoffs of 0.5, 10, 30, and 50 kDa
(YM membranes for 10, 30, and 50 kDa and YC membrane
for 0.5 kDa). The membranes result in minimal retention of
proteins (including albumin) at concentrations above 0.1
mg/ml (data on file at Amicon).
Procedures. Haptenation of penicillin to serum proteins
was determined by adding 44,000 dpm of tritiated penicillin
(in 50 ,ul of PBS) along with unlabeled benzylpenicillin (in 50
,ul of PBS) to each milliliter of serum or 4.6% human albumin
in PBS tested. The total reaction solution volume was 1 to 2
ml, depending on the number of time points at which
samples were collected. The mixtures were incubated at
37°C for up to 72 h. At specified times, 110-pul aliquots were
removed from each mixture for determination of amounts of
penicillin bound to albumin. The concentration of unlabeled
penicillin was varied from 1 to 1,000 p,M and did not affect
1463
ANTIMICROB. AGENTS CHEMOTHER.
haptenation of labeled penicillin. The data reported below
are for 1,000 ,uM penicillin G.
Each aliquot was treated as follows. To 110 RI of protein
solution in which penicillin was incubated (serum or albu-
min), 1.5 ml of 3% trichloroacetic acid was added to precip-
itate proteins. The mixture was centrifuged (500 x g for 10
min at 20°C), and the supernatant was removed by vacuum.
The precipitate was redissolved in 3 ml of PBS, and then
protein was reprecipitated with 0.3 ml of 30% trichloroacetic
acid. This redissolution-and-precipitation procedure was re-
peated a total of three times. The final protein pellet was
dissolved in 150 ,ul of 0.5 N sodium hydroxide. The solution
was placed in a scintillation vial, 4 ml of scintillation cocktail
was added, and radioactivity was assayed with a beta
counter and reported as counts per minute. All assays were
performed in triplicate, and results were reported as means
with standard deviations (SD). Background activity was
determined from samples assayed as described above, ex-
cept that precipitation and washing were initiated within 10 s
of addition of labeled penicillin. For each test sample, the
reported result in counts per minute is the net value of the
counts per minute determined minus the background counts
per minute.
A variety of protein-containing solutions were prepared
and used in the experiments described below. These in-
cluded the following: intact human serum; serum which had
been concentrated by ultrafiltration (under nitrogen pres-
sure) with a 30- or 10-kDa-cutoff membrane, washed with
multiple volumes of PBS (diaflowed), and then reconstituted
to the original volume with PBS; serum which had been
concentrated by ultrafiltration with a 30- or 10-kDa-cutoff
membrane, diaflowed, and then reconstituted to the original
volume with serum ultrafiltrate (prepared with a 10- or
30-kDa-cutoff membrane); 4.6 or 7.2% human serum albu-
min (fraction V) diluted in PBS; 4.6% human serum albumin
(fraction V) diluted in ultrafiltrate from serum (with a 10- or
30-kDa-cutoff membrane); 4.6% human serum albumin
(crystallized and lyophilized fraction V) diluted in PBS; 4.6%
human serum albumin (crystallized and lyophilized fraction
V) diluted in ultrafiltrate from serum (with a 10- or 30 k-Da-
cutoff membrane); 4.6% human serum albumin (100% elec-
trophoretically pure) diluted in PBS; 4.6% human serum
albumin (100% electrophoretically pure) diluted in ultrafil-
trate from serum (obtained with a 10- or 30-kDa-cutoff
membrane); 2.6% IgG diluted in PBS, pH 7.4; and 2.6% IgG
with human serum albumin (fraction V) in PBS, pH 7.4. For
all albumin solutions, the pH was adjusted to 7.3 to 7.4. With
the above-described protein solutions and procedures, a
number of comparisons of serum, ultrafiltered serum, and
albumin solutions were made.
Modification of penicillin binding to serum. An experiment
was conducted to determine whether the putative factors
responsible for increased penicillin binding could be re-
moved from serum by ultrafiltration. The protein-containing
solutions compared were intact serum, ultrafiltered serum
diaflowed through a 30-kDa-cutoff membrane and reconsti-
tuted with PBS, and ultrafiltered serum diaflowed and recon-
stituted with serum ultrafiltrate (prepared with a 30-kDa-
cutoff membrane). Labeled penicillin and unlabeled
penicillin were added as described above, and the mixtures
were incubated for 48 h.
The potency of the serum haptenation-facilitating factor(s)
was assessed by reconstitution of serum that was ultrafil-
tered, diaflowed, and concentrated with serum ultrafiltrate
(obtained with a 30-kDa-cutoff membrane) and PBS at vari-
ous ratios (100, 75, 50, 25, and 0% ultrafiltrate) by using the
incubation methods described above.
Characterization of haptenation facilitation factor(s). To
characterize the haptenation-facilitating factor in serum,
ultrafiltrate was prepared from intact serum by using mem-
branes with molecular size cutoffs of 0.5, 10, 30, and 50 kDa.
Serum that was ultrafiltered, diaflowed, and concentrated
was then reconstituted by using each of these filtrates and
compared with intact serum and 4.6% human serum albumin
(fraction V) in PBS. The six test materials were studied by
using the procedures described above and 48 h of incubation.
We then determined whether serum cations (calcium and
magnesium) are the factors required for facilitated penicillin
haptenation in 4.6% human serum albumin (fraction V) in
PBS. The above-described procedures were followed for
incubation and sample processing. Test materials included
intact serum, 4.6% human serum albumin (fraction V) in
PBS, 4.6% human serum albumin (fraction V) in PBS with
2.5 mM calcium (as calcium chloride), and 4.6% human
serum albumin (fraction V) in PBS with 0.78 mM magnesium
(as magnesium chloride). Serum that was ultrafiltered, dia-
flowed, and reconstituted with PBS was also tested by
addition of 2.5 mM calcium or 0.78 mM magnesium.
Effect of albumin purity on penicillin binding. Since the
fraction V human serum albumin used in the initial experi-
ments was labeled as 96 to 99% pure, it was possible that
non-albumin-haptenating factors from serum were present.
Therefore, we determined whether albumin purity influences
the extent to which penicillin binds. Three 4.6% human
serum albumin products varying in purity were studied, i.e.,
fraction V, recrystallized and lyophilized fraction V, and
100% electrophoretically pure human serum albumin. Each
was diluted in PBS and in serum ultrafiltrate (prepared from
a 10-kDa-cutoff membrane), and the pH was adjusted to 7.3
to 7.4. The procedure described above was then followed,
with the same amounts of labeled and unlabeled penicillin
added, incubation time, wash and precipitation steps, and
counting.
Haptenation kinetics. To investigate further the binding to
intact serum and 100% pure human serum albumin reconsti-
tuted with serum ultrafiltrate, a kinetic study was done with
seven determinations over the first 24 h.
RESULTS
Comparison of intact serum with 4.6% human serum
albumin (fraction V in PBS). After incubation for 72 h with
labeled penicillin, the mean binding of penicillin to intact
serum was almost fivefold higher than with 4.6% human
serum albumin (fraction V) (6,161 ± 1,272 versus 1,270 +-
141 cpm). Binding of penicillin appeared to plateau by 24 h
for both protein solutions (Fig. 1). In a separate study (data
not shown), when the human serum albumin concentration
was increased to 7.2%, so that total protein concentrations
were similar to that of intact serum, the extent of penicillin
binding increased insignificantly, to 26% from 19.5% of the
binding with intact serum. This suggests that there are
factors in serum that enhance binding to albumin or that
there are other substances in serum to which penicillin binds
selectively.
In a related experiment, we determined whether immuno-
globulin can account for the differences between penicillin
binding to serum and penicillin binding to 4.6% human serum
albumin. The protein solutions tested included intact serum,
4.6% human serum albumin (fraction V) in PBS, 4.6%
human serum albumin (fraction V) with 2.6% IgG in PBS
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FIG. 1. Relative extent of penicillin binding to intact serum (0)
or human serum albumin (0) over 72 h at 37°C (± SD).
with the pH adjusted to 7.4, and 2.6% IgG alone in PBS with
the pH adjusted to 7.4. For intact serum and the solution of
human serum albumin plus IgG, the total protein concentra-
tion was the same (7.2%). IgG at 2.6% added to 4.6% human
serum albumin increased penicillin binding by about 25%,
but the penicillin binding still did not approach that of intact
serum. With intact serum, 4.6% human serum albumin in
PBS, 4.6% human serum albumin plus 2.6% IgG, and 2.6%
IgG as test materials, the mean + SD counts per minute
bound were 5,658 160, 1,638 ± 206, 2,046 ± 176, and 740
± 111, respectively. These data demonstrate that the pres-
ence of IgG does not account for the differences in penicillin
binding between serum and human serum albumin.
Modulation of penicillin haptenation with ultrafiltration.
Ultrafiltration of serum was found to reduce penicillin bind-
ing. Penicillin binding was 7,400 ± 288 cpm with intact
serum, 2,113 ± 195 cpm with serum diaflowed and reconsti-
tuted with PBS, and 6,082 ± 306 cpm with serum diaflowed
and reconstituted with serum ultrafiltrate. The binding of
serum that had been ultrafiltered and reconstituted with PBS
was 29% of that of intact serum. However, when the
ultrafiltered serum was reconstituted with serum ultrafil-
trate, the binding capacity was restored to 82% of that of
intact serum. Serum ultrafiltrate alone showed minimal
penicillin binding (96.4 ± 7 cpm). This experiment demon-
strated that the haptenation-facilitating factors in serum are
less than 30 kDa and can be removed to some extent and
then restored to serum.
The serum factor(s) retained almost its full ability to
facilitate penicillin haptenation at up to a dilution of 1 to 2
with PBS. The results are shown in Table 1. Beyond 1 to 2
dilutions, the facilitation activity was reduced in a concen-
tration-dependent manner.
Characterization of haptenation factor(s). Reconstitution of
serum with ultrafiltrate from 0.5-, 10-, 30-, and 50-kDa-cutoff
membranes substantially increased penicillin binding com-
pared with 4.6% albumin in PBS. The results are shown in
Table 2. This demonstrates that a major component of the
haptenation activity is below 0.5 kDa.
TABLE 1. Effect of dilution of serum concentrate reconstitution
fluid on penicillin haptenation
% of serum reconstitution fluid
that was: Net cpm
Serum PBS bound + SD
ultrafiltrate PS
100 0 6,081 ± 306
75 25 6,072 ± 212
50 50 5,506 ± 69
25 75 4,214 111
0 100 2,112 ± 195
Addition of calcium or magnesium did not increase peni-
cillin haptenation of human serum albumin or ultrafiltered
and diaflowed serum. Penicillin binding was 6,287 + 341 cpm
for intact serum, 2,188 + 98 cpm for human serum albumin
without calcium or magnesium, 1,811 t 123 cpm for human
serum albumin with calcium, and 1,772 ± 121 cpm for human
serum albumin with magnesium. Binding of ultrafiltered and
diaflowed serum was 3,791 ± 245 cpm with no added
cations, 3,171 ± 65 cpm with calcium added, and 3,571 ± 58
cpm with magnesium added. Calcium and magnesium did
not appear to be the facilitating factors.
Effect of albumin purity on penicillin binding. The extent to
which penicillin bound to human serum albumin was directly
related to albumin purity (Fig. 2). For each type of albumin,
dilution in serum ultrafiltrate increased the extent of binding
almost twofold. With the purest human serum albumin
diluted in serum ultrafiltrate, the extent of binding was
equivalent to that of intact serum (data not shown). When
4.6% electrophoretically pure human serum albumin was
diluted with ultrafiltrate from human serum albumin fraction
V (obtained with a 10-kDa-cutoff membrane), penicillin
binding was decreased compared with dilution with PBS
(3,375 ± 54 versus 3,834 ± 89 cpm, respectively), suggesting
that a factor in the fraction V human serum albumin prepa-
ration inhibited haptenation.
Haptenation kinetics. The relationship of penicillin binding
with time is shown in Fig. 3. By using linear regression to
determine the slope of each line, we found average rates of
binding to penicillin of 131 cpm/h for serum and 66 cpm/h for
the human serum albumin solution. Therefore, the initial rate
of binding to reconstituted purified human serum albumin
was much less than the rate of binding to intact serum,
suggesting that higher-molecular-weight factors in serum
modulate penicillin haptenation.
Studies of sera from non-penicillin-allergic patients. Sera
TABLE 2. Effects of various-molecular-weight ultrafiltrates on
restoration of penicillin-facilitated haptenation to
diaflowed serum
Tetmaterial Mean cpmTest matenal bound ± SD
Intact serum ................................... 7,611 ± 162
4.6% human serum albumin (fraction V) in PBS........ 2,078 ± 134
Ultrafiltered serum reconstituted with
ultrafiltrate from:
50-kDa membrane................................... 6,869 ± 20
30-kDa membrane................................... 5,946 ± 180
10-kDa membrane................................... 5,680 + 180
0.5-kDa membrane................................... 6,564 ± 47
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FIG. 2. Effect of albumin purity on binding of penicillin recon-
stituted with either PBS (0) or serum ultrafiltrate (I).
from seven subjects that were documented not to possess
detectable anti-penicilloyl IgE were available. Penicillin
binding averaged 4,914 + 643 cpm (range, 3,550 to 5,388
cpm), while it was 2,780 ± 125 for 4.6% human serum
albumin in PBS.
DISCUSSION
These studies confirm and extend the preliminary report of
Lee and Sullivan (2) regarding facilitated haptenation of
penicillin to serum proteins. We demonstrated that a fac-
tor(s) in serum indeed facilitates covalent binding of penicil-
lin to serum proteins. The factor can be removed from serum
by ultrafiltration, and when returned to the serum it restores
penicillin binding. When serum ultrafiltrate is added to
human serum albumin, penicillin binding is increased but at
0.
0
-o
C)._
C
I
cO
Time (hours)
FIG. 3. Kinetics of penicillin binding to serum proteins (-) or to
100% electrophoretically pure human serum albumin reconstituted
with serum ultrafiltrate (0).
Haptenating factors
-.
.
.: ....h .. {...... .... a
I I I
Serum Fraction V Reconstituted 100% Pure
Albumin
FIG. 4. Proposed model of penicillin haptenation and dehapte-
nation factors in serum and albumin fractions based on observed
relative penicillin binding.
a rate less than that for intact serum. It appears that at least
one component of the facilitation factor is less than 0.5 kDa,
which suggests that it is not a peptide and that it is some
simple serum component other than calcium or magnesium.
We did not attempt to define the factor(s) further.
In the studies with whole serum, we did not determine the
percentage of penicillin that is bound to proteins other than
albumin. Studies with purified IgG demonstrated minimal
binding to this fraction. Also, negligible binding to serum
ultrafiltrate suggests that small peptides are not important as
sites for penicillin binding. The study with 100% pure human
serum albumin demonstrated an extent of binding similar to
that obtained with intact serum and suggests that similar
numbers of binding sites are available in serum and 4.6%
albumin.
The demonstration that albumin purity influences penicil-
lin haptenation suggests that there are also factors which
inhibit penicillin haptenation. It appears that purification of
albumin removes the inhibitory factors. With the presence of
inhibitory and facilitating haptenation factors, the extent and
rate of penicillin binding depend on the net effect. A pro-
posed model compatible with the data is that with intact
serum, facilitating factors predominate in effect (Fig. 4).
With the preparation of human serum albumin fraction V,
much of the facilitation factor is removed while some of the
inhibitory factors are not. Thus, the net effect with fraction
V human serum albumin is a relatively low rate of penicillin
haptenation. With further purification of human serum albu-
min, the inhibitory factors are removed, allowing facilitating
factors to predominate. This is in agreement with the lower
rate of haptenation with 100% pure human serum albumin in
serum ultrafiltrate compared with intact serum.
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No direct relationship has been established between the
extent of penicillin bound to serum proteins and the risk of
penicillin allergy. Penicillin sensitivity also relates to mech-
anisms involved in antigen presentation and IgE production.
However, even at some low level, production of penicilloyl-
albumin conjugate should be associated with reactivity since
current models of type I hypersensitivity assume that
bivalent penicilloyl-albumin is required to cross-link IgE on
basophils or mast cells.
These studies support the hypothesis that there are factors
in serum which facilitate and inhibit penicillin haptenation to
serum proteins. Perhaps these factors could partially explain
the heterogeneity of immune responsiveness to penicillin in
patients, although this possibility was not investigated in our
study. Further studies are needed to determine the relation-
ship between facilitated haptenation and the immune re-
sponse.
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